// STATE LEGISLATION TRACKER

Ohio HB 52: Revise the practice of certified registered nurse anesthetists

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Ohio
Bill: HB 52
Session: 136
Filed: 2025-02-04
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Ohio HB52 revises the practice rules for certified registered nurse anesthetists, mainly around anesthesia care and CRNA scope. Based on the bill title, subjects, and status, it does not appear to change peptide access, compounded peptides, off-label prescribing, telehealth, naturopathic practice, NP peptide prescribing, FDA 503A/503B compounding, controlled substances, or PDMP rules.

Key Points

No clear change to compounded peptide access in Ohio
No clear change to off-label prescribing rules for peptides
No clear change to telehealth prescribing or peptide consults
No clear change to naturopathic or nurse practitioner peptide scope
Main effect appears limited to CRNA anesthesia practice

What to Watch For

Note CRNA scope changes may matter for procedural settings, but not routine peptide prescribing.

Note No obvious FDA 503A, 503B, pharmacy, or compounding peptide impact from the bill title and subjects.

Note No obvious controlled-substance or prescription-monitoring change for peptide users.

Where the Bill Stands

The bill was signed by the governor on March 10, 2026 and became effective on June 9, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws